Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,057 DKK | +2.75% | -0.34% | -4.50% |
21/05 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
15/05 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.50% | 18.8B | |
+9.42% | 114B | |
+13.26% | 107B | |
-7.19% | 22.22B | |
-1.69% | 21.28B | |
-5.96% | 17.51B | |
-39.36% | 17.17B | |
+7.38% | 14.14B | |
+35.18% | 12.2B | |
+17.20% | 8.01B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- SVB Securities Adjusts Price Target on Genmab A/S to $36 From $33, Maintains Market Perform Rating